This article reviews the pathogenesis, epidemiology, diagnosis, and treatment of this
nosocomial and potentially fatal infectious diarrhea, as well as the associated risk factors …

Clostridium difficile (C. difficile) is a Gram-positive, spore-forming, anaerobic bacillus, which
is widely distributed in the intestinal tract of humans and animals and in the environment. In …

Abstract Scope In 2009, the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) published the first treatment guidance document for Clostridioides …

Triptolide (TP), a traditional Chinese medicine, has been reported to be effective in the
treatment of autoimmune diseases and exerting antineoplastic activity in several human …

Clostridium difficileinfection (CDI) is a leading cause of hospital-associated gastrointestinal
illness and places a high burden on our health-care system. Patients with CDI typically have …

Background: To date, evidence for the efficacy of fecal microbiota transplantation (FMT) in
recurrent Clostridium difficile infection (CDI) has been limited to case series and open-label …

Foreword This Journal feature begins with a case vignette highlighting a common clinical
problem. Evidence supporting various strategies is then presented, followed by a review of …

Background. The incidence and severity of Clostridium difficile–associated diarrhea (CDAD)
has been increasing, and there have been recent reports of metronidazole treatment failure …

OBJECTIVES: Patients who are immunocompromised (IC) are at increased risk
ofClostridium difficileinfection (CDI), which has increased to epidemic proportions over the …

Meta-Analysis of Probiotics for the Prevention of Antibiotic... : Official journal of the American
College of Gastroenterology | ACG Meta-Analysis of Probiotics for the Prevention of Antibiotic …